background image

Press Releases

Feb 23, 2021

Day One Expands Clinical-Stage Oncology Pipeline; Announces Global License Agreement with Merck KGaA, Darmstadt, Germany to Develop and Commercialize MEK Inhibitor Pimasertib

Read more...

Feb 17, 2021

Day One Appoints Charles N. York II as Chief Operating and Financial Officer and Expands Board of Directors with the Addition of Natalie Holles

Read more...

Feb 10, 2021

Day One Announces $130 Million Series B Financing to Accelerate New Targeted Cancer Treatments for Children

Read more...
Displaying 11 - 13 of 13